These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 3130347)
1. H-ras p21 and peanut lectin immunoreactivity of hyperplastic, preneoplastic and neoplastic urinary bladder lesions in rats. Ward JM; Hagiwara A; Tsuda H; Tatematsu M; Ito N Jpn J Cancer Res; 1988 Feb; 79(2):152-5. PubMed ID: 3130347 [TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation. Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438 [TBL] [Abstract][Full Text] [Related]
3. Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans. Ward JM; Perantoni AO; Santos E Oncogene; 1989 Feb; 4(2):203-13. PubMed ID: 2648257 [TBL] [Abstract][Full Text] [Related]
4. H-ras activation and ras p21 expression in bladder tumors induced in F344/NCr rats by N-butyl-N-(4-hydroxybutyl)nitrosamine. Enomoto T; Ward JM; Perantoni AO Carcinogenesis; 1990 Dec; 11(12):2233-8. PubMed ID: 2265474 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical cellular distribution of proteins related to M phase regulation in early proliferative lesions induced by tumor promotion in rat two-stage carcinogenesis models. Yafune A; Taniai E; Morita R; Akane H; Kimura M; Mitsumori K; Shibutani M Exp Toxicol Pathol; 2014 Jan; 66(1):1-11. PubMed ID: 23890812 [TBL] [Abstract][Full Text] [Related]
6. Enhanced immunoreactivity of ras oncogene p21 protein in urinary bladder epithelium of rats treated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide. Masui T; Ward JM; Cohen SM Cancer Lett; 1991 Aug; 59(2):95-102. PubMed ID: 1884376 [TBL] [Abstract][Full Text] [Related]
7. Activation of H-ras oncogene in rat bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine. Fujita J; Ohuchi N; Ito N; Reynolds SH; Yoshida O; Nakayama H; Kitamura Y J Natl Cancer Inst; 1988 Mar; 80(1):37-43. PubMed ID: 3276902 [TBL] [Abstract][Full Text] [Related]
8. Nonspecific esterase reaction in hyperplastic urinary bladder epithelium induced by administration of N-butyl-N-(4-hydroxybutyl)nitrosamine, freezing and formalin instillation in rats. Akagi A; Otsuka H Br J Exp Pathol; 1988 Jun; 69(3):367-77. PubMed ID: 3390388 [TBL] [Abstract][Full Text] [Related]
9. Activating missense mutations in Ha-ras-1 genes in a malignant subset of bladder lesions induced by N-butyl-N-(4-hydroxybutyl)nitrosamine or N-[4-(5-nitro-2-furanyl)-2-thiazolyl]formamide. Jones RF; Debiec-Rychter M; Zukowski K; Wang CY Mol Carcinog; 1990; 3(6):393-402. PubMed ID: 2278634 [TBL] [Abstract][Full Text] [Related]
10. Summation effects of uracil and other promoters on epithelial lesion development in the F344 rat urinary bladder initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine. de Camargo JL; Shirai T; Kato T; Asamoto M; Fukushima S Jpn J Cancer Res; 1991 Nov; 82(11):1220-5. PubMed ID: 1752781 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical Expression of Cyclin D1, Cytokeratin 20, and Uroplakin III in Proliferative Urinary Bladder Lesions Induced by o-Nitroanisole in Fischer 344/N Rats. Willson CJ; Flake GP; Sills RC; Kissling GE; Cesta MF Vet Pathol; 2016 May; 53(3):682-90. PubMed ID: 26319780 [TBL] [Abstract][Full Text] [Related]
12. Oncogene expression of FANFT- or BBN-induced rat urothelial cells. Debiec-Rychter M; Jones RF; Zukowski K; Wang CY Int J Cancer; 1990 Nov; 46(5):913-8. PubMed ID: 2228319 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of c-Ha-ras oncogene p21 product in pre-neoplastic and neoplastic lesions during hepatocarcinogenesis in rats. Galand P; Jacobovitz D; Alexandre K Int J Cancer; 1988 Jan; 41(1):155-61. PubMed ID: 3275589 [TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical localization of RasHa p21 in normal and neoplastic cells in fixed tissue sections from Harvey sarcoma virus-infected mice. Ward JM; Pardue RL; Junker JL; Takahashi K; Shih TY; Weislow OS Carcinogenesis; 1986 Apr; 7(4):645-51. PubMed ID: 3516433 [TBL] [Abstract][Full Text] [Related]
15. Short-term screening of promoters of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats. Miyata Y; Fukushima S; Hirose M; Masui T; Ito N Jpn J Cancer Res; 1985 Sep; 76(9):828-34. PubMed ID: 3932281 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of keratin in proliferative bladder epithelium induced by freezing, cyclophosphamide or N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in the rat. Hasegawa R; Cohen SM Carcinogenesis; 1985 Mar; 6(3):409-14. PubMed ID: 2579745 [TBL] [Abstract][Full Text] [Related]
17. Absence of ras oncogene activation in rat urinary bladder carcinomas induced by N-methyl-N-nitrosourea or N-butyl-N-(4-hydroxybutyl)nitrosamine. Masui T; Mann AM; Macatee TL; Okamura T; Garland EM; Smith RA; Cohen SM Carcinogenesis; 1992 Dec; 13(12):2281-5. PubMed ID: 1473235 [TBL] [Abstract][Full Text] [Related]
18. Comparison of enzyme phenotypes in human bladder tumours and experimentally induced hyperplastic and neoplastic lesions of the rat urinary bladder. A combined histochemical and immunohistochemical approach. Tsuda H; Inoue T; Asamoto M; Fukushima S; Ito N; Okamura T; Ohtaguro K; Washida H; Satoh K; Amelizad Z Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 56(5):307-16. PubMed ID: 2565627 [TBL] [Abstract][Full Text] [Related]
19. Cell line specific abnormalities in expression of PNA, SBA and L-PHA binding sites by carcinogen induced rat urothelial carcinomas. Rak JW; Debiec-Rychter M; Miller FR; Wang CY Neoplasma; 1992; 39(3):141-6. PubMed ID: 1528317 [TBL] [Abstract][Full Text] [Related]
20. Characterization of an N-methyl-N-nitrosourea-induced autochthonous rat bladder cancer model. Steinberg GD; Brendler CB; Ichikawa T; Squire RA; Isaacs JT Cancer Res; 1990 Oct; 50(20):6668-74. PubMed ID: 2208131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]